2025-07-11 - Analysis Report
Okay, here's a report analyzing Hims & Hers Health Inc (HIMS) based on the provided data, formatted as requested:

## Hims & Hers Health Inc (HIMS) Stock Analysis

**Company Overview:** Hims & Hers Health Inc is a telehealth company that offers personalized health and wellness solutions directly to consumers.

### 1. Performance vs. S&P 500 (VOO)

**Key Metrics:**

*   **HIMS Cumulative Return:** 185.43%
*   **VOO (S&P 500) Cumulative Return:** 64.76%
*   **Absolute Divergence:** 122.67 (HIMS outperformance)
*   **Relative Divergence:** 56.0 (Indicates HIMS's current outperformance relative to VOO falls within the 56th percentile of its historical range)

**Analysis of Alpha and Beta:**

| Year       | CAGR    | MDD    | Alpha  | Beta  | Cap(B) |
| ---------- | ------- | ------ | ------ | ----- | ------ |
| 2019-2021  | -46.0%  | 51.0%  | -84.0% | -0.0 | 1.5    |
| 2020-2022  | -15.0%  | 72.1%  | -17.0% | -0.0 | 1.4    |
| 2021-2023  | -51.0%  | 72.1%  | -69.0% | -0.1 | 2.0    |
| 2022-2024  | 127.0% | 78.4%  | 101.0% | -0.1 | 5.4    |
| 2023-2025  | 180.0% | 78.4%  | 132.0% | -0.1 | 11.2   |

*   **CAGR (Compound Annual Growth Rate):** Varies significantly year to year, from large losses to substantial gains. The most recent period (2023-2025) shows significant growth.
*   **MDD (Maximum Drawdown):** Consistently high, indicating significant volatility and risk.
*   **Alpha:** The alpha values are highly variable, from large negative values, to large positive values, depending on the period.
*   **Beta:** The beta values are negative, indicating a negative correlation between the stock and the market, which is counter-intuitive.
*   **Cap (B):** Indicates the company's market capitalization in billions. There is a clear trend of increasing capitalization over the past few years.

### 2. Recent Stock Price Movement

**Key Metrics:**

*   **Current Price:** $50.27
*   **Last-market:** {'price': 50.27, 'previousClose': 51.24, 'change': -1.89}
*   **5-Day Moving Average:** $49.72
*   **20-Day Moving Average:** $51.52
*   **60-Day Moving Average:** $48.21

**Analysis:**

The stock price has decreased from the previous close (change = -1.89), suggesting a recent downward trend. The current price is below the 20-day moving average but above the 5-day and 60-day moving averages, indicating a mixed short-term trend.

### 3. Technical Indicators & Expected Return

**Key Metrics:**

*   **Market Risk Indicator (MRI):** 0.3373 (Low Risk)
*   **RSI (Relative Strength Index):** 37.58 (Approaching oversold territory)
*   **PPO (Percentage Price Oscillator):** -0.08 (Negative, indicating potential downtrend)
*   **Hybrid Signal:** cash_69%_Sell 1.5% of holdings (19 shares - Caution - MRI:0.34)
*   **Recent (20-day) Relative Divergence Change:** -0.5 (Short-term decline)
*   **Expected Return:** -16.1% (Projected underperformance vs. S&P 500 over 2+ years)

**Analysis:**

*The MRI suggests a period of low risk. The RSI is approaching oversold territory. The PPO being negative supports a downtrend. The Hybrid Signal indicates a cautious stance, suggesting a reduction in holdings. The negative expected return indicates a potential for underperformance relative to the S&P 500.* The price change from the previous close ({'price': 50.27, 'previousClose': 51.24, 'change': -1.89}) suggests some downside momentum.

### 4. Recent News & Significant Events

*   **2025-07-11:** HIMS in headlines due to major business developments, regulatory changes, or market events.
*   **2025-07-07:** Analysts discussing HIMS's performance and outlook in context of industry trends and global economic factors.
*   **2025-07-10:** HIMS stock shows notable volatility, influenced by recent news, earnings reports, or executive actions.
*   **2025-07-08:** Market experts highlight risks and opportunities for HIMS, advising investors to monitor recent news and company announcements.

**Analysis:**

Recent news suggests that the stock is subject to market volatility and significant events, which could be opportunities or risks. Monitoring news and company announcements is advised.

### 5. Recent Earnings Analysis

| 날짜       | EPS  | 매출      |
| ---------- | ---- | --------- |
| 2025-05-05 | 0.22 | 0.59 B$   |
| 2024-11-04 | 0.35 | 0.40 B$   |
| 2024-08-05 | 0.06 | 0.32 B$   |
| 2024-05-06 | 0.05 | 0.28 B$   |
| 2025-05-05 | 0.05 | 0.28 B$   |

**Analysis:**

The EPS (Earnings Per Share) and revenue have generally been increasing over the past few quarters, suggesting improving financial performance. However, the most recent EPS shows a decrease from 0.35 to 0.22, indicating potential concerns about the company's recent performance.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
| ------------ | -------- | ------------- |
| 2025-03-31   | $0.59B   | 73.50%        |
| 2024-12-31   | $0.48B   | 76.81%        |
| 2024-09-30   | $0.40B   | 79.16%        |
| 2024-06-30   | $0.32B   | 81.30%        |
| 2024-03-31   | $0.28B   | 82.36%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE      |
| ------------ | -------- | -------- |
| 2025-03-31   | $0.55B   | 9.01%   |
| 2024-12-31   | $0.48B   | 5.46%   |
| 2024-09-30   | $0.44B   | 17.18%  |
| 2024-06-30   | $0.36B   | 3.67%   |
| 2024-03-31   | $0.34B   | 3.23%   |

**Analysis:**

*   **Revenue and Profitability:** Revenue has been consistently increasing quarter over quarter. While revenue increased, the profit margin has declined over the past few quarters.
*   **Capital and Profitability:** Equity has increased over the past few quarters. The ROE (Return on Equity) has fluctuated, with the most recent quarter showing a decrease.

### 7. Overall Analysis & Conclusion

**Summary:**

Hims & Hers Health Inc. (HIMS) has significantly outperformed the S&P 500 (VOO) based on cumulative returns, but with high volatility as shown by the MDD and variable alpha. While recent revenue growth is encouraging, declining profit margins and a negative expected return warrant caution. Technical indicators present a mixed picture: the MRI is low, but the RSI indicates the stock is approaching oversold territory.

**Conclusion:**

Based on this data, HIMS presents a high-risk, high-reward investment opportunity. The recent decline in price, earnings, and profit margin, coupled with negative expected returns, suggest potential near-term headwinds. Investors should carefully monitor news and company developments, manage risk appropriately, and consider a cautious approach given the high volatility and uncertain outlook.
